Pain Therapeutics, Inc. (NASDAQ:PTIE)

CAPS Rating: 3 out of 5

A biopharmaceutical company that develops novel drugs for pain management and oncology.

Recs

0
Player Avatar tking123 (54.17) Submitted: 6/26/2011 9:26:15 AM : Outperform Start Price: $4.00 PTIE Score: -9.86

Pain drug bet

Report this Post Reply

Featured Broker Partners


Advertisement